these were the most frequently reported AEs across all treatment arms but they were mostly transient and mild/moderate in severity, consistent with the safety profile of the GLP-1RA drug class [8, 18, 24]
Retatrutide With retatrutide , there arent official safety warnings yet since its still in clinical trials
The FDA-approved brand-name medications in these same drug classes are Ozempic and Wegovy (containing semaglutide, manufactured by Novo Nordisk) and Mounjaro and Zepbound (containing tirzepatide, manufactured by Eli Lilly) - all FDA-reviewed for safety, efficacy, and quality, which compounded versions are not
AbundRX GLP-1 Pricing: What's Confirmed and What Isn't Per the official website reviewed July 29, 2026, pricing starts at $99 for the semaglutide-based option and $149 for the tirzepatide-based option, both listed with free shipping
Effects of D-Allulose with Sucrose Beverage on Glucose Tolerance and Insulin Levels among Thai Healthy Volunteers